Guardant Health to Participate in Upcoming Investor Conferences
Guardant Health, a leader in precision oncology, announced participation in key investor conferences. The company will be present at the Canaccord Genuity 44th Annual Growth Conference in Boston, MA, with a fireside chat scheduled on Tuesday, August 13 at 10:30 a.m. ET. Additionally, Guardant Health will partake in a panel discussion on the Future of Cancer Screening at the UBS Genomic Medicine Summit in Dana Point, CA, on Wednesday, August 14 at 2:45 p.m. PT.
Live and archived webcasts of these sessions will be available on the “Investors” section of the Guardant Health website. Further details can be accessed at: www.guardanthealth.com.
Guardant Health, leader nell'oncologia di precisione, ha annunciato la sua partecipazione a importanti conferenze per investitori. L'azienda sarà presente alla 44ª Conferenza Annuale sulla Crescita di Canaccord Genuity a Boston, MA, con un incontro informale programmato per martedì, 13 agosto, alle 10:30 ET. Inoltre, Guardant Health parteciperà a una discussione di panel sul Futuro dello Screening del Cancro al Summit di Medicina Genomica UBS a Dana Point, CA, mercoledì, 14 agosto, alle 14:45 PT.
Webcast in diretta e registrati di queste sessioni saranno disponibili nella sezione “Investitori” del sito web di Guardant Health. Maggiori dettagli possono essere consultati su: www.guardanthealth.com.
Guardant Health, líder en oncología de precisión, anunció su participación en conferencias clave para inversores. La empresa estará presente en la 44ª Conferencia Anual de Crecimiento de Canaccord Genuity en Boston, MA, con un charla informativa programada para el martes, 13 de agosto, a las 10:30 a.m. ET. Además, Guardant Health participará en una mesa redonda sobre el Futuro de la Detección del Cáncer en el Summit de Medicina Genómica de UBS en Dana Point, CA, el miércoles, 14 de agosto, a las 2:45 p.m. PT.
Las transmisiones en vivo y grabadas de estas sesiones estarán disponibles en la sección “Inversores” del sitio web de Guardant Health. Se puede acceder a más detalles en: www.guardanthealth.com.
Guardant Health, 정밀 종양학의 선두주자, 주요 투자자 회의에 참여한다고 발표했습니다. 이 회사는 매사추세츠주 보스턴에서 열리는 캐너코드 제뉴이티 제44회 연간 성장 회의에 참여하며, 8월 13일 화요일 오전 10시 30분 ET에 화로 옆 대담이 예정되어 있습니다. 또한, Guardant Health는 캘리포니아주 다나 포인트에서 열리는 UBS 유전체 의학 정상 회담에서 암 검진의 미래에 관한 패널 토론에도 참여합니다. 토론은 8월 14일 수요일 오후 2시 45분 PT에 진행됩니다.
이 세션의 실시간 및 아카이브 웹캐스트는 Guardant Health 웹사이트의
- None.
- None.
-
Canaccord Genuity 44th Annual Growth Conference in
Boston, MA
Fireside chat on Tuesday, August 13 at 10:30 a.m. ET
-
UBS Genomic Medicine Summit in
Dana Point, CA
Panel discussion: Future of Cancer Screening on Wednesday, August 14 at 2:45 p.m. PT
Interested parties may access live and archived webcasts of the sessions on the “Investors” section of the company website at: www.guardanthealth.com.
About Guardant Health
Guardant Health is a leading precision oncology company focused on guarding wellness and giving every person more time free from cancer. Founded in 2012, Guardant is transforming patient care and accelerating new cancer therapies by providing critical insights into what drives disease through its advanced blood and tissue tests, real-world data and AI analytics. Guardant tests help improve outcomes across all stages of care, including screening to find cancer early, monitoring for recurrence in early-stage cancer, and treatment selection for patients with advanced cancer. For more information, visit guardanthealth.com and follow the company on LinkedIn, X (Twitter) and Facebook.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240808212181/en/
Investor Contact:
Zarak Khurshid
investors@guardanthealth.com
Media Contact:
Melissa Marasco
press@guardanthealth.com
+1 650-647-3711
Source: Guardant Health, Inc.
FAQ
What conferences will Guardant Health participate in?
When is Guardant Health's fireside chat at the Canaccord Genuity 44th Annual Growth Conference?
What topic will Guardant Health discuss at the UBS Genomic Medicine Summit?
How can I access the webcasts of Guardant Health's investor conference sessions?
What is the stock symbol for Guardant Health?
